Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
10.16
0.66 (6.95%)
At close: May 12, 2025, 3:59 PM
10.67
4.97%
Pre-market: May 13, 2025, 04:05 AM EDT
6.95% (1D)
| Bid | 8.36 |
| Market Cap | 774.93M |
| Revenue (ttm) | 56.42M |
| Net Income (ttm) | -208.4M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -3.64 |
| Forward PE | -2.81 |
| Analyst | Buy |
| Ask | 12 |
| Volume | 652,650 |
| Avg. Volume (20D) | 985,706 |
| Open | 9.94 |
| Previous Close | 9.50 |
| Day's Range | 9.82 - 10.38 |
| 52-Week Range | 8.18 - 29.56 |
| Beta | 2.24 |
About NRIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+6.78%
Nurix Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
+6.53%
Nurix Therapeutics shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and announced a price target of $35.
